ReviewFrontiers in immunology2022

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections.

Monica D Reece et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.